Fresenius Kabi USA LLC

Form 483 issued August 24, 2023 · Melrose Park, Illinois

Inspection
Aug 14 – Aug 24, 2023
Observations
1
Pages
3
FEI number
1450022

In short: On August 24, 2023, FDA issued a Form 483 with 1 observation to Fresenius Kabi USA LLC in Melrose Park, Illinois (FEI 1450022) after an inspection that ran Aug 14 – Aug 24, 2023. The investigators were Chad W. Rice and Nicholas J. Presto. Most observations concern quality system; the most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.22(d) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit are not in…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Fresenius Kabi USA LLC?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit). The opening words of each observation are shown on this page.

Who inspected Fresenius Kabi USA LLC?

Chad W. Rice and Nicholas J. Presto are named on this Form 483, for the inspection of Aug 14 – Aug 24, 2023. Each investigator has a profile showing what they cite most.

When was Fresenius Kabi USA LLC inspected by FDA?

The inspection ran Aug 14 – Aug 24, 2023, and the Form 483 is dated August 24, 2023.

How do I get the full Form 483 for Fresenius Kabi USA LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free